Notes:
I. The shareholding structure of the Company and subsidiaries above is as per 30th November 2024.
II. Rejuve Global Investment Pte. Ltd is controlled by Lee Ee Ling.
III. The Company’s Subsidiaries are as follow:
- PYFA HEALTH SINGAPORE PTE.LTD., which is engaged in other holding companies. The company has started its investment in Pyfa Health Singapore Pte. Ltd as of 2020.
- PT PYFA AETHERIA INDONESIA, which is engaged, among others, wholesale trading of pharmaceutical drugs and wholesale trading of cosmetics. It was established on March 2021.
- PT PYFA INVESTAMA INDONESIA, which is engaged, among others, holding company activities and large trade with fees or based on contracts. It was established on March 2021.
- PT PYFA SEHAT INDONESIA, which is engaged, among others, wholesale trading of milk and dairy products and wholesale trading of other food and beverages. It was established on March 2021.
- PT HOLI PHARMA, which is engaged, among others, industry of manufacture of pharmaceutical products for human. It was acquired by the Company on Desember 2021.
- PT ETHICA INDUSTRI FARMASI, which is engaged, among others, industry of manufacture of pharmaceutical products for human. It was acquired by the Company on July 2022.
- PYFA AUSTRALIA PTY LTD, controlled company established on November 2023.
- PROBIOTEC PTY LTD, and its subsidiaries, which are engaged, among others, a manufacturer and packer of various kinds of pharmaceuticals. It was acquired by the Company indirectly through Pyfa Australia Pty Ltd on June 2024.